Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lumakras
Biotech
Merck's early KRAS data suggest combination-friendly safety
Merck showcased its KRAS inhibitor at ESMO, suggesting the drug may be able to overcome some of the challenges that have troubled others in the space.
Annalee Armstrong
Oct 23, 2023 9:45am
Next round of KRAS drugs follow footsteps of Amgen and Mirati
May 4, 2023 6:00am
AACR: Lilly challenges Amgen, Mirati with early KRAS data
Apr 17, 2023 2:30pm
Sanofi sets Revolution back, sending lead asset to the docks
Dec 8, 2022 7:14am
Mirati is once again the subject of takeover talks: report
Nov 23, 2022 11:27am
Amgen avoids 'low-hanging fruit' in tackling undruggable targets
Jun 29, 2022 3:00pm